Dysregulation of mitotic machinery genes precedes genome instability during spontaneous pre-malignant transformation of mouse ovarian surface epithelial cells

BackgroundBased in epidemiological evidence, repetitive ovulation has been proposed to play a role in the origin of ovarian cancer by inducing an aberrant wound rupture-repair process of the ovarian surface epithelium (OSE). Accordingly, long term cultures of isolated OSE cells undergo in vitro spontaneous transformation thus developing tumorigenic capacity upon extensive subcultivation. In this work, C57BL/6 mouse OSE (MOSE) cells were cultured up to passage 28 and their RNA and DNA copy number profiles obtained at passages 2, 5, 7, 10, 14, 18, 23, 25 and 28 by means of DNA microarrays. Gene ontology, pathway and network analyses were focused in passages earlier than 20, which is a hallmark of malignancy in this model.ResultsAt passage 14, 101 genes were up-regulated in absence of significant DNA copy number changes. Among these, the top-3 enriched functions (>30 fold, adj p < 0.05) comprised 7 genes coding for centralspindlin, chromosome passenger and minichromosome maintenance protein complexes. The genes Ccnb1 (Cyclin B1), Birc5 (Survivin), Nusap1 and Kif23 were the most recurrent in over a dozen GO terms related to the mitotic process. On the other hand, Pten plus the large non-coding RNAs Malat1 and Neat1 were among the 80 down-regulated genes with mRNA processing, nuclear bodies, ER-stress response and tumor suppression as relevant terms. Interestingly, the earliest discrete segmental aneuploidies arose by passage 18 in chromosomes 7, 10, 11, 13, 15, 17 and 19. By passage 23, when MOSE cells express the malignant phenotype, the dysregulated gene expression repertoire expanded, DNA imbalances enlarged in size and covered additional loci.ConclusionPrior to early aneuploidies, overexpression of genes coding for the mitotic apparatus in passage-14 pre-malignant MOSE cells indicate an increased proliferation rate suggestive of replicative stress. Concomitant down-regulation of nuclear bodies and RNA processing related genes suggests altered control of nuclear RNA maturation, features recently linked to impaired DNA damage response leading to genome instability. These results, combined with cytogenetic analysis by other authors in this model, suggest that transcriptional profile at passage 14 might induce cytokinesis failure by which tetraploid cells approach a near-tetraploid stage containing primary chromosome aberrations that initiate the tumorigenic drive.

[1]  M. Zanetti,et al.  Immune modulation by ER stress and inflammation in the tumor microenvironment. , 2016, Cancer letters.

[2]  Eva M. Schmelz,et al.  In vitro model of spontaneous mouse OSE transformation. , 2013, Methods in molecular biology.

[3]  M. Quinn,et al.  Epithelial–mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: An exception to the norm , 2007, Journal of cellular physiology.

[4]  E. Schwob,et al.  Excess MCM proteins protect human cells from replicative stress by licensing backup origins of replication , 2008, Proceedings of the National Academy of Sciences.

[5]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[6]  D. Altieri,et al.  Survivin modulates microtubule dynamics and nucleation throughout the cell cycle. , 2005, Molecular biology of the cell.

[7]  R. Kurman,et al.  Two Types of Ovarian Cortical Inclusion Cysts: Proposed Origin and Possible Role in Ovarian Serous Carcinogenesis , 2015, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[8]  Zongwei Li,et al.  Glucose regulated protein 78: a critical link between tumor microenvironment and cancer hallmarks. , 2012, Biochimica et biophysica acta.

[9]  K. Chin,et al.  LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer , 2009, Oncogene.

[10]  Ie-Ming Shih,et al.  The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory , 2010, The American journal of surgical pathology.

[11]  A. Godwin,et al.  Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity. , 1994, Cancer research.

[12]  Yin-hua Yu,et al.  Luteinizing hormone upregulates survivin and inhibits apoptosis in ovarian epithelial tumors. , 2011, European journal of obstetrics, gynecology, and reproductive biology.

[13]  Eva M. Schmelz,et al.  Changes in Gene Expression and Cellular Architecture in an Ovarian Cancer Progression Model , 2011, PloS one.

[14]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[15]  A. Krämer,et al.  Centrosome amplification in tumorigenesis. , 2012, Cancer letters.

[16]  J. Ellenberg,et al.  NuSAP, a mitotic RanGTP target that stabilizes and cross-links microtubules. , 2006, Molecular biology of the cell.

[17]  E. He,et al.  The proliferation marker thymidine kinase 1 in clinical use. , 2013, Molecular and clinical oncology.

[18]  M. Fathalla,et al.  Incessant ovulation and ovarian cancer – a hypothesis re-visited , 2013, Facts, views & vision in ObGyn.

[19]  RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer. , 2015, Carcinogenesis.

[20]  E. Zabarovsky,et al.  Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties , 2012, Oncogene.

[21]  Ho-Joon Lee,et al.  PTEN loss and HOXA10 expression are associated with ovarian endometrioid adenocarcinoma differentiation and progression. , 2013, Carcinogenesis.

[22]  Zhongming Zhao,et al.  TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes , 2015, Nucleic Acids Res..

[23]  J L Pace,et al.  Development of a syngeneic mouse model for events related to ovarian cancer. , 2000, Carcinogenesis.

[24]  Gayatry Mohapatra,et al.  Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer. , 2014, Carcinogenesis.

[25]  Helena Carreira,et al.  Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) , 2015, The Lancet.

[26]  B. Lopez,et al.  Replication Stress in Mammalian Cells and Its Consequences for Mitosis , 2015, Genes.

[27]  S. Itzkovitz,et al.  Nuclear Retention of mRNA in Mammalian Tissues , 2015, Cell reports.

[28]  Amy S. Lee,et al.  Role of the unfolded protein response, GRP78 and GRP94 in organ homeostasis , 2015, Journal of cellular physiology.

[29]  Xiaolin Wu,et al.  WebaCGH: an interactive online tool for the analysis and display of array comparative genomic hybridisation data. , 2006, Applied bioinformatics.

[30]  C. Sette,et al.  The interplay between DNA damage response and RNA processing: the unexpected role of splicing factors as gatekeepers of genome stability , 2015, Front. Genet..

[31]  U. Urzúa,et al.  Microarray Comparative Genomic Hybridization Profile of a Murine Model for Epithelial Ovarian Cancer Reveals Genomic Imbalances Resembling Human Ovarian Carcinomas , 2005, Tumor Biology.

[32]  G. Jayson,et al.  Ovarian Cancer Cell Heparan Sulfate 6-O-Sulfotransferases Regulate an Angiogenic Program Induced by Heparin-binding Epidermal Growth Factor (EGF)-like Growth Factor/EGF Receptor Signaling , 2014, The Journal of Biological Chemistry.

[33]  Yulun Huang,et al.  Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling , 2016, Cell Death and Disease.

[34]  N. Ahmed,et al.  Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research , 2013, Front. Oncol..

[35]  Michael Q. Zhang,et al.  Regulating Gene Expression through RNA Nuclear Retention , 2005, Cell.

[36]  J. Powell,et al.  Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: Functional similarity to the human disease and identification of prospective tumoral markers and targets , 2006, Journal of cellular physiology.

[37]  P. Hartge,et al.  Hormonal risk factors and invasive epithelial ovarian cancer risk by parity , 2013, British Journal of Cancer.

[38]  W. Dynan,et al.  Characterization of DNA binding and pairing activities associated with the native SFPQ·NONO DNA repair protein complex. , 2015, Biochemical and biophysical research communications.

[39]  C. Holman,et al.  In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk. , 2013, Gynecologic oncology.

[40]  Fathalla Mf Incessant ovulation and ovarian cancer - a hypothesis re-visited. , 2013 .

[41]  Kylie L. Gorringe,et al.  An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice. , 2012, The Journal of clinical investigation.

[42]  C. Sorenson,et al.  CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression. , 2009, Blood.

[43]  Takahide Yokoi,et al.  NEAT1 long noncoding RNA regulates transcription via protein sequestration within subnuclear bodies , 2014, Molecular biology of the cell.

[44]  N. Yanaihara,et al.  Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts. , 2009, Oncology reports.

[45]  Jun Zhou,et al.  Increases urinary HMGA1 in serous epithelial ovarian cancer patients. , 2015, Cancer biomarkers : section A of Disease markers.

[46]  Eva M. Schmelz,et al.  Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model. , 2005, Neoplasia.

[47]  H. Gogas,et al.  Survivin beyond physiology: orchestration of multistep carcinogenesis and therapeutic potentials. , 2014, Cancer letters.

[48]  G. Rodriguez,et al.  Ovarian cancer: etiology, risk factors, and epidemiology. , 2012, Clinical obstetrics and gynecology.

[49]  Mayumi Kitagawa,et al.  The chromosomal passenger complex (CPC) as a key orchestrator of orderly mitotic exit and cytokinesis , 2015, Front. Cell Dev. Biol..

[50]  P. Leung,et al.  Ovarian surface epithelium: biology, endocrinology, and pathology. , 2001, Endocrine reviews.

[51]  Sam W. Lee,et al.  Expression of the p53 target CDIP correlates with sensitivity to TNFα-induced apoptosis in cancer cells. , 2012, Cancer research.

[52]  Jean-Jacques Daudin,et al.  Evaluation of the gene-specific dye bias in cDNA microarray experiments , 2005, Bioinform..

[53]  U. Urzúa,et al.  Tumor and reproductive traits are linked by RNA metabolism genes in the mouse ovary: a transcriptome-phenotype association analysis , 2010, BMC Genomics.

[54]  Song-yan Li,et al.  Tolerance to endoplasmic reticulum stress mediates cisplatin resistance in human ovarian cancer cells by maintaining endoplasmic reticulum and mitochondrial homeostasis. , 2015, Oncology reports.

[55]  John J McGuire,et al.  Anticancer antifolates: current status and future directions. , 2003, Current pharmaceutical design.

[56]  S. Kondo,et al.  Clinical significance of RacGAP1 expression at the invasive front of gastric cancer , 2014, Gastric Cancer.

[57]  D. Marsh,et al.  Gonadotropin signalling in epithelial ovarian cancer. , 2012, Cancer letters.

[58]  G. Fountzilas,et al.  Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial , 2012, Cancer Chemotherapy and Pharmacology.

[59]  A. Gross,et al.  Luteinizing hormone-induced caspase activation in rat preovulatory follicles is coupled to mitochondrial steroidogenesis. , 2007, Endocrinology.

[60]  Yongliang Zhang,et al.  GRP94/gp96 in Cancer: Biology, Structure, Immunology, and Drug Development. , 2016, Advances in cancer research.

[61]  Wei Zhang,et al.  Tetraploid cells from cytokinesis failure induce aneuploidy and spontaneous transformation of mouse ovarian surface epithelial cells , 2012, Cell cycle.

[62]  L. D. White,et al.  Molecular and Functional Characteristics of Ovarian Surface Epithelial Cells Transformed by KrasG12D and loss of Pten in a Mouse Model in vivo , 2011, Oncogene.

[63]  C. Bond,et al.  Paraspeckles: nuclear bodies built on long noncoding RNA , 2009, The Journal of cell biology.

[64]  W. Murdoch,et al.  Oxidative Damage to DNA of Ovarian Surface Epithelial Cells Affected by Ovulation: Carcinogenic Implication and Chemoprevention , 2004, Experimental biology and medicine.

[65]  S. Ben-Dor,et al.  Reactive oxygen species are indispensable in ovulation , 2011, Proceedings of the National Academy of Sciences.

[66]  B. Farkas,et al.  Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis. , 2013, Obstetrics and gynecology.

[67]  E. Lengyel,et al.  MMP-2 functions as an early response protein in ovarian cancer metastasis , 2009, Cell cycle.

[68]  Terry Speed,et al.  Normalization of cDNA microarray data. , 2003, Methods.